ArticleFrontiers in oncology2026

Acalabrutinib treatment in relapsed/refractory primary cutaneous diffuse large B cell lymphoma, leg type. Case report.

David A Martinez-Gamboa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.